What Is Perimenopause And Why Has No One Talked to You About It?
Perimenopause is one of the most significant hormonal transitions a woman experiences, yet it remains one of the least discussed in routine healthcare. Many women spend years struggling with symptoms they cannot explain, not realizing that the root cause is the natural hormonal shift happening in their own bodies.
Perimenopause — from the Greek peri, meaning “around” is the transitional phase leading up to menopause. It is the period during which the ovaries gradually produce less estrogen and progesterone, ovulation becomes irregular, and the menstrual cycle begins to change. It ends 12 months after the final menstrual period, the point at which menopause is officially confirmed.
According to the Stages of Reproductive Aging Workshop (STRAW +10) the internationally recognized framework for classifying reproductive aging, published in the Journal of Clinical Endocrinology & Metabolism (2012) . Perimenopause begins when a woman first notices consistent changes in her cycle length and ends one full year after her last period.
The most important thing to understand: perimenopause is not menopause. And for many women, it begins far earlier than expected.
When Does Perimenopause Start?
This is where most women are surprised.
The Study of Women’s Health Across the Nation (SWAN) found that perimenopausal symptoms begin at a median age of 47.5 years, with many women noticing the first signs in their late 30s or early 40s.
A study published in Obstetrics & Gynecology (2006) confirmed that cycle irregularity, the hallmark early sign of perimenopause, typically precedes the final menstrual period by an average of 4 years, with a range of 1 to 10+ years.
The average duration of perimenopause is 4–8 years. For some women, it lasts as few as 2 years. For others, it extends beyond 10.
This means millions of women in their late 30s and 40s are experiencing perimenopause without knowing it.
The Symptoms of Perimenopause: More Than Just Hot Flashes
Perimenopause affects far more than just the menstrual cycle. Because estrogen receptors are found throughout the brain, heart, bones, skin, bladder, and vagina, declining and fluctuating hormone levels produce a wide range of symptoms that can feel confusing and disconnected.
The most common perimenopause symptoms include:
Menstrual Changes Irregular cycles are typically the first sign. Periods may become shorter, longer, heavier, lighter, or simply unpredictable. Skipped periods followed by the return of bleeding are common.
Vasomotor Symptoms Hot flashes and night sweats affect approximately 75–80% of women during perimenopause, according to the North American Menopause Society (NAMS). The SWAN study found that these symptoms can begin years before the final period and may last a total of 7–11 years in women who start experiencing them during perimenopause.
Sleep Disruption Night sweats fragment sleep, but estrogen and progesterone also have direct neurological effects on sleep architecture. A study published in the Journal of Clinical Sleep Medicine found that perimenopausal women had significantly higher rates of insomnia and poor sleep quality than premenopausal women.
Mood Changes This is one of the most underrecognized aspects of perimenopause. Fluctuating estrogen directly affects serotonin, dopamine, and norepinephrine, the brain’s mood-regulating neurotransmitters. A landmark study in Archives of General Psychiatry found that perimenopausal women were 2–4 times more likely to experience a major depressive episode than premenopausal women even with no prior history of depression.
New-onset anxiety, irritability, and emotional lability during the 40s are frequently perimenopause not a midlife crisis, not anxiety disorder, not personal weakness.
Brain Fog Difficulty concentrating, forgetting words, and mental “fuzziness” are widely reported during perimenopause. Research published in Menopause (2014) confirmed measurable declines in verbal memory and processing speed during the perimenopausal transition changes that typically improve once hormone levels stabilize postmenopausally.
Vaginal and Urinary Changes Declining estrogen reduces the thickness and elasticity of vaginal tissue, causing dryness, discomfort, and increased susceptibility to urinary tract infections. These symptoms, collectively termed Genitourinary Syndrome of Menopause (GSM), affect nearly 50% of perimenopausal and postmenopausal women, according to research in Menopause.
Joint Pain and Fatigue Estrogen has anti-inflammatory properties. Its decline during perimenopause is associated with increased joint stiffness, musculoskeletal discomfort, and a pervasive fatigue that rest does not fully resolve.
How Is Perimenopause Diagnosed?
For women over 45 with typical symptoms and cycle changes, perimenopause is generally a clinical diagnosis based on symptoms and menstrual history, without requiring blood tests.
For women under 45, laboratory testing is recommended to:
- Confirm hormonal changes (FSH, estradiol, LH)
- Exclude other causes of similar symptoms — particularly thyroid disorders, hyperprolactinemia, and premature ovarian insufficiency (POI)
Key tests in the perimenopausal workup:
- FSH and estradiol — elevated FSH supports perimenopause, though levels fluctuate widely and a single result is not definitive
- TSH — thyroid dysfunction mimics many perimenopause symptoms
- AMH (Anti-Müllerian hormone) — the most accurate marker of remaining ovarian reserve; can estimate how far along the transition may be
- Complete blood count — to assess for anemia if heavy bleeding is present
Because FSH fluctuates dramatically during perimenopause, a single “normal” or “elevated” result should not be used in isolation to confirm or rule out the diagnosis.
Treatment Options: You Do Not Have to Suffer Through Perimenopause
This is perhaps the most important message of this entire guide: perimenopause symptoms are not something you simply have to endure. Effective, evidence-based treatments exist and they can significantly restore quality of life.
Lifestyle Foundations Regular exercise, a Mediterranean-style anti-inflammatory diet, optimized sleep hygiene, and stress reduction strategies form the foundation of perimenopause management for every woman. These interventions meaningfully improve vasomotor symptoms, mood, cognitive function, bone health, and metabolic health during the transition.
Hormone Therapy (HT) For women with moderate-to-severe symptoms, hormone therapy remains the most effective available treatment more effective than any supplement or non-hormonal medication for the full symptom spectrum. The Menopause Society’s 2022 Position Statement affirms that for healthy women under 60 and within 10 years of menopause onset, the benefits of HT outweigh the risks.
Perimenopausal women who are still having periods typically require a different hormonal regimen than postmenopausal women often using cyclic progestogen to maintain cycle regularity while managing symptoms. Low-dose hormonal contraceptives (such as the pill, patch, or ring) also serve a dual function during perimenopause: providing contraception (important, as pregnancy remains possible) and managing hormonal fluctuations.
Non-Hormonal Options For women who cannot or prefer not to use HT, several non-hormonal options have meaningful evidence:
- Fezolinetant (Veozah) — FDA-approved NK3 receptor antagonist that reduces hot flash frequency by approximately 59% (JAMA, 2023)
- SSRIs/SNRIs (paroxetine, venlafaxine, escitalopram) — effective for vasomotor symptoms and mood
- Cognitive Behavioral Therapy (CBT) — shown in The Lancet (2012) to significantly reduce the perceived impact of hot flashes and improve sleep and mood
Local Vaginal Estrogen For vaginal dryness, discomfort, and recurrent UTIs, low-dose local vaginal estrogen is highly effective with minimal systemic absorption, making it appropriate for most women, including many who cannot take systemic HT.
Perimenopause vs. Menopause: The Key Difference
| Perimenopause | Menopause | |
| Definition | Transition phase with hormonal fluctuation | 12 consecutive months without a period |
| Periods | Irregular, unpredictable | Absent |
| Pregnancy possible? | Yes — contraception still needed | No |
| Hormone levels | Fluctuating, erratic | Consistently low |
| Duration | 4–8 years on average | A single point in time |
When to See a Doctor
Schedule an evaluation if you are experiencing:
- Cycle changes that concern you — particularly very heavy bleeding or periods lasting longer than 7 days
- Hot flashes or night sweats disrupting your sleep or daily life
- Mood changes — anxiety, depression, or irritability that feel new or out of character
- Fatigue or brain fog that is affecting your work or relationships
- Vaginal dryness or pain with intercourse
- Any bleeding after 12 months without a period (this always requires prompt evaluation)
You do not have to wait until symptoms become unbearable. Proactive evaluation even when symptoms are mild allows for earlier intervention, better outcomes, and more options.
Frequently Asked Questions
Can I be in perimenopause at 38? Yes. While the average onset is around 47, perimenopause can begin in the late 30s. If you are under 40 and experiencing cycle changes or symptoms, evaluation is important to distinguish early perimenopause from premature ovarian insufficiency (POI), which has different implications.
Is perimenopause the same as “the change”? “The change” typically refers to the broader menopausal transition, which encompasses both perimenopause and menopause. Perimenopause is the active transitional phase; menopause is the specific milestone of 12 months without a period.
Can I get pregnant during perimenopause? Yes. Irregular ovulation does not mean no ovulation. Until 12 full months have passed without a period, contraception is still needed if pregnancy is not desired.
The Bottom Line
Perimenopause is not a phase to simply “get through.” It is a years-long hormonal transition with real, measurable effects on physical health, mental wellbeing, and long-term disease risk. Understanding what is happening in your body and knowing that effective care exists, puts you in control of this transition rather than at its mercy.
The women who navigate perimenopause best are those who recognize it early, seek knowledgeable care, and take proactive steps, not those who wait until symptoms become overwhelming.
Schedule Your Women’s Health Appointment with IVANA MD
Wondering if what you are experiencing is perimenopause? Not sure where to start? At IVANA MD, our experienced women’s health team provides comprehensive perimenopause evaluations, personalized treatment planning, and the compassionate, unhurried care every woman deserves during this transition.
You deserve answers and relief.
Call: 346-585-4077
4220 Cartwright Road, Suite 201, Missouri City, Texas 77459
This blog is for educational purposes only and does not constitute medical advice. Always consult a qualified women’s health provider for evaluation and treatment of perimenopause symptoms.
References
- Harlow, S. D., Gass, M., Hall, J. E., Lobo, R., Maki, P., Rebar, R. W., … & de Villiers, T. J. (2012). Executive summary of the Stages of Reproductive Aging Workshop + 10. Journal of Clinical Endocrinology & Metabolism, 97(4), 1159–1168. https://doi.org/10.1210/jc.2011-3362
- Avis, N. E., Crawford, S. L., Greendale, G., Bromberger, J. T., Everson-Rose, S. A., Gold, E. B., … & Thurston, R. C. (2015). Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Internal Medicine, 175(4), 531–539. https://doi.org/10.1001/jamainternmed.2014.8063
- Cohen, L. S., Soares, C. N., Vitonis, A. F., Otto, M. W., & Harlow, B. L. (2006). Risk for new onset of depression during the menopausal transition. Archives of General Psychiatry, 63(4), 385–390. https://doi.org/10.1001/archpsyc.63.4.385
- Weber, M. T., Maki, P. M., & McDermott, M. P. (2014). Cognition and mood in perimenopause: a systematic review and meta-analysis. Journal of Steroid Biochemistry and Molecular Biology, 142, 90–98. https://doi.org/10.1016/j.jsbmb.2013.06.001
- Nappi, R. E., & Kokot-Kierepa, M. (2012). Vaginal Health: Insights, Views & Attitudes (VIVA) results from an international survey. Climacteric, 15(1), 36–44. https://doi.org/10.3109/13697137.2011.647840
- The Menopause Society (formerly NAMS). (2022). The 2022 Menopause Society Hormone Therapy Position Statement. Menopause, 29(7), 767–794. https://doi.org/10.1097/GME.0000000000002028
- Neal-Perry, G., Venkat, A., Osman, H., Syms, C., Kaur, R., Bhatt, A., … & Pinkerton, J. V. (2023). Efficacy and safety of fezolinetant in moderate-to-severe vasomotor symptoms. JAMA, 329(13), 1093–1103. https://doi.org/10.1001/jama.2023.4086
- Ayers, B., Smith, M., Hellier, J., Mann, E., & Hunter, M. S. (2012). Effectiveness of group and self-help cognitive behavior therapy in reducing problematic menopausal hot flushes. Menopause, 19(7), 749–759. https://doi.org/10.1097/gme.0b013e31823fe835
